Drawing based on the label description. No photo yet.
“The capsules are axially printed with MYLAN over SM 50 in black ink on cap and body”
MYLAN SM 50 pill
Pill with imprint MYLAN SM 50 is yellow, capsule, 22 mm and has been identified as Sunitinib Malate 50 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Mylan Pharmaceuticals Inc.
Sunitinib Malate 50 mg
- Imprint
- MYLAN SM 50
- Strength
- 50 mg
- Used for
- Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
- Color
- Yellow
- Shape
- Capsule / oblong
- Size
- 22 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Mylan Pharmaceuticals Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 0378-6680, 0378-6680-28
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Sunitinib Malate used for?
Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Gastrointestinal Stromal Tumor
Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
Advanced Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).
Adjuvant Treatment of Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
Advanced Pancreatic Neuroendocrine Tumors
Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows MYLAN SM 50. The parts can be split between the two sides, so turn the pill over and check both.
- It is yellow, capsule, 22 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Sunitinib Malate
Inactive: Silicon Dioxide, Croscarmellose Sodium, Gelatin, Unspecified, Magnesium Stearate, Mannitol, Sodium Lauryl Sulfate, Titanium Dioxide, Ferric Oxide Yellow, Ammonia, Ferrosoferric Oxide, Propylene Glycol, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA19A
Lenalidomide 10 mg
Blue & yellow, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
JSP 507
Butalbital, Aspirin, Caffeine and Codeine Phosphate 50 mg / 325 mg / 40 mg / 30 mg
Blue & yellow, capsule, 22 mm
Used for headache
Schedule III
-
R 8
Fenoprofen Calcium 300 mg
Orange & yellow, capsule, 23 mm
Used for pain and rheumatoid arthritis
-
K 16
Indomethacin 75 mg
White & yellow, capsule, 22 mm
Used for pain and rheumatoid arthritis
-
L82
Fenofibric Acid 135 mg
Blue & yellow, capsule, 22 mm
Used for high cholesterol and high triglycerides
-
AN 596
Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg
Red & yellow, capsule, 23 mm
Other Sunitinib Malate pills
- SC 12 5 Sunitinib Malate 12.5 mg Gray, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- MYLAN SM 12 5 Sunitinib Malate 12.5 mg Pink, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- STN 12 5 Sunitinib Malate 12.5 mg Yellow, capsule, 11 mm Used for renal cell carcinoma and pancreatic neoplasms
- RM53 RM53 Sunitinib Malate 12.5 mg Brown, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- S12 5 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- 6 MS Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- TEVA 8199 TEVA 8199 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- Pfizer STN 12 5 mg Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms